Evernorth Pharmacy Benefit Services adjusted revenues measure the issuer-defined revenue base of Cigna's Pharmacy Benefit Services operating segment.
Q2 2026 adjusted revenues were $34.496B, up 8% from $31.954B a year earlier. Cigna said drug mix was the primary driver of that growth.
Drug mix can overwhelm prescription-count trends
The segment's pharmacy claim volume fell 2% in the quarter, yet revenue increased. That is why claims composition must be analyzed separately from utilization: the types of prescriptions, channels, and drug costs in the claim base can change revenue without requiring more claims.
Adjusted revenues are non-GAAP and use Cigna's own exclusions. The metric is useful for studying the operating segment, not for treating PBM revenue definitions as standardized across competitors.
Primary source: The Cigna Group Q2 2026 Form 10-Q filed with the SEC.
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare PBM revenue growth
Compare pharmacy-benefit revenue growth alongside claim volume and claims composition without assuming standardized PBM definitions.
Explore more topics in the Financial Research Encyclopedia.